AstraZeneca will pay $1.2 billion upfront to CSPC for eight obesity candidates, with milestone payments potentially lifting the deal to $18.5 billion.
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
British pharmaceutical company AstraZeneca's manufacturing site in Macclesfield, northwest England. 2014 File Photo / Agence France-Presse CHICAGO — Treating breast cancer patients with AstraZeneca’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results